Shares in Mind Medicine (MNMD) are surging, following a shift in market sentiment regarding possible growth and the potential ...

The main focus in Teva’s innovative portfolio continues to be neuroscience and immunology, with clinical trials for three key assets underway: olanzapine for treatment of schizophrenia, ...

A number of factors - chiefly, the bird flu - is causing you to pay more for eggs at the market than ever. Will the price of ...

Amgen AMGN reported fourth-quarter 2024 adjusted earnings of $5.31 per share, which beat the Zacks Consensus Estimate of ...

Merck (NYSE: MRK) recently released its Q4 results, with revenues and earnings exceeding the street estimates.

Sales of Novo Nordisk’s (NVO) blockbuster weight-loss drug Wegovy doubled in the fourth quarter, but the Danish ...

Danish drugmaker Novo Nordisk reported fourth quarter and full year 2024 earnings Wednesday, beating Wall Street's ...

Experts are calling on the government to implement strategies that will better predict future Ozempic shortages.

A pecan nut product that was recalled due to undeclared walnuts has been given a Class II classification by the food agency.

Trump on Saturday had directed that 25% tariffs on most imports from the two American partners — and 10% on Canadian energy ...

A handful of healthcare stocks got a boost after President Trump said Friday his administration would “love and cherish Social Security, Medicare, and Medicaid.” ...

Some of the best health care stocks for February 2025, based on 30-day returns, include Akero Therapeutics Inc., Guardant Health Inc., and Inari Medical Inc. The best-performing health care stocks in ...